MDT Q1 2024 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.7B+4.5% YoY

Gross Profit

$5.1B65.9% margin

Operating Income

$1.3B16.5% margin

Net Income

$791M10.3% margin

EPS (Diluted)

$0.59

QoQ Revenue Growth

-9.9%

Cash Flow

Operating Cash Flow

$875M

Free Cash Flow

$521M

Stock-Based Comp.

$73M

Balance Sheet

Total Assets

$90.8B

Total Liabilities

$39.4B

Stockholders' Equity

$51.2B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.7B	$7.4B	+4.5%
Gross Profit	$5.1B	$4.9B	+4.5%
Operating Income	$1.3B	$1.1B	+12.7%
Net Income	$791M	$929M	-14.9%

Revenue Segments

Cardiovascular

$2.9B37%

Neuroscience Group

$2.2B29%

Medical Surgical

$2.0B26%

Diabetes Group

$578M8%

Other

$16M0%

Geographic Segments

UNITED STATES

$3.9B51%

Total Other Countries, Excluding United States and Ireland

$3.7B49%

IRELAND

$29M0%